Singapore markets open in 6 hours 19 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,066.85 +31.16 (+0.62%) Dow
38,194.60 +378.68 (+1.00%) Nasdaq
15,793.31 +135.49 (+0.87%) Bitcoin USD
58,403.15 -1,879.41 (-3.12%) CMC Crypto 200
1,205.14 -133.93 (-10.00%)
ABT May 2024 121.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:29PM EDT. Market open.
| Previous close | 0.2800 |
| Open | 0.3200 |
| Bid | 0.0000 |
| Ask | 0.0900 |
| Strike | 121.00 |
| Expiry date | 2024-05-10 |
| Day's range | 0.2800 - 0.3200 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.